Determination of insulin in innovative formulations by means of LC coupled to fluorescence detection
- 15 December 2008
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 48 (5) , 1303-1309
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Why Diabetes Incidence Increases—A Unifying TheoryAnnals of the New York Academy of Sciences, 2006
- Subcutaneous delivery of insulin loaded poly(fumaric-co-sebacic anhydride) microspheres to type 1 diabetic ratsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2006
- A Quantitative Assessment of the Significance of Molecular Mobility as a Determinant for the Stability of Lyophilized Insulin FormulationsPharmaceutical Research, 2005
- Insulin Nanoparticles: A Novel Formulation Approach for Poorly Water Soluble Zn-InsulinPharmaceutical Research, 2004
- Skin-Related Complications of Insulin TherapyAmerican Journal of Clinical Dermatology, 2003
- Oral insulin delivery1Abbreviations: GI, gastrointestinal; IDDM, insulin-dependent diabetes mellitus; IU, international units; NIDDM, non-insulin-dependent diabetes mellitus; PIN, phase inversion nanoencapsulation; ZOT, zona occludens toxin.1Advanced Drug Delivery Reviews, 1999
- Controlled Insulin Release from Chitosan MicroparticlesArchiv der Pharmazie, 1998
- Preparation and characterization of a peptide containing w/o emulsionInternational Journal of Pharmaceutics, 1995
- Uptake and translocation of microparticles in small intestineDigestive Diseases and Sciences, 1995
- Purification and analysis of the major components of chum salmon protamine contained in insulin formulations using high-performance liquid chromatographyProtein Expression and Purification, 1990